Palle Bach Nielsen Fruekilde

Mr. Palle Bach Nielsen Fruekilde

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in Clinical Nutrition
Verified
Journal Article
Closed access
SLSine Lykkedegn
Sine Lykkedegn
SBSigne Sparre Beck-Nielsen
Signe Sparre Beck-Nielsen
GSGrith Lykke Sørensen
Grith Lykke Sørensen
LALouise Bjoerkholt Andersen
Louise Bjoerkholt Andersen
PFPalle Bach Nielsen Fruekilde
Palle Bach Nielsen Fruekilde
HChenrik thybo christesen
henrik thybo christesen

1 July 2016 in Journal of the American Society of Hypertension
Verified
Journal Article
Closed access
LALouise Bjørkholt Andersen
Louise Bjørkholt Andersen
MGMichaela Golic
Michaela Golic
ŁPŁukasz Przybył
Łukasz Przybył
GSGrith Lykke Sørensen
Grith Lykke Sørensen
JJjan stener jørgensen
jan stener jørgensen
NHNadine Haase
Nadine Haase

22 May 2024 in Acta Obstetricia et Gynecologica Scandinavica
Verified
Journal Article
Open access
NRNete Lundager Klokker Rausgaard
Nete Lundager Klokker Rausgaard
IIInge Olga Ibsen
Inge Olga Ibsen
PFPalle Bach Nielsen Fruekilde
Palle Bach Nielsen Fruekilde
ENEllen Aagaard Nøhr
Ellen Aagaard Nøhr
PDPer Damkier
Per Damkier
Pernille RavnPernille Ravn
Pernille Ravn
Introduction: There is a paucity of objectively verified data on substance use among Danish pregnant women. We estimated the prevalence of substance use including alcohol and nicotine among the general population of Danish pregnant women.Material and Methods: In this anonymous, national, cross‐sectional, descriptive study, pregnant women were invited when attending an ultrasound scan between November 2019 and December 2020 at nine Danish hospitals. Women submitted a urine sample and filled out a questionnaire. Urine samples were screened on‐site with a qualitative urine dipstick for 15 substances including alcohol, nicotine, opioids, amphetamines, cannabis, and benzodiazepines. All screen‐positive urine samples underwent secondary quantitative analyses with gold standard, liquid chromatography‐tandem mass spectrometry (LC–MS/MS) analysis. Results were compared to questionnaire information to analyze the validity of self‐reporting and to examine possible cross‐reactions.Results: A total of 1903 of 2154 invited pregnant women participated (88.3%). The prevalence of dipstick‐positive urine samples was 25.0%. 44.0% of these were confirmed positive, resulting in a total confirmed prevalence of 10.8%. The prevalence of nicotine use was 10.1%—and for all other substances, <0.5%. Nicotine use was more prevalent among younger pregnant women, while other substance use appeared evenly distributed over age groups. Self‐reporting of use of nicotine products was high (71.1%), but low for cannabis and alcohol intake (0% and 33.3%, respectively). Prescription medication explained almost all cases of oxycodone, methylphenidate, and benzodiazepine use.Conclusions: Substance use among pregnant women consisted mainly of nicotine. Dipstick screening involved risks of false negatives and false positives. Except for alcohol intake and cannabis use, dipstick analyses did not seem to provide further information than self‐reporting. LC–MS/MS analyses remain gold standard, and future role of dipstick screenings should be discussed.

Verified
Journal Article
Open access
PDF file
HBHans Christian Beck
Hans Christian Beck
ASAsmus Cosmos Skovgaard
Asmus Cosmos Skovgaard
AMAfsaneh Mohammadnejad
Afsaneh Mohammadnejad
NPNicolai Bjødstrup Palstrøm
Nicolai Bjødstrup Palstrøm
PFPalle Bach Nielsen Fruekilde
Palle Bach Nielsen Fruekilde
Mette  SørensenMette Sørensen
Mette Sørensen
Acute myocardial infarction (AMI) is a major cause of mortality and morbidity worldwide, yet biomarkers for AMI in the short- or medium-term are lacking. We apply the discordant twin pair design, reducing genetic and environmental confounding, by linking nationwide registry data on AMI diagnoses to a survey of 12,349 twins, thereby identifying 39 twin pairs (48–79 years) discordant for their first-ever AMI within three years after blood sampling. Mass spectrometry of blood plasma identified 715 proteins. Among 363 proteins with a call rate > 50%, imputation and stratified Cox regression analysis revealed seven significant proteins (FDR < 0.05): FGD6, MCAM, and PIK3CB reflected an increased level in AMI twins relative to their non-AMI co-twins (HR > 1), while LBP, IGHV3-15, C1RL, and APOC4 reflected a decreased level in AMI twins relative to their non-AMI co-twins (HR < 1). Additional 50 proteins were nominally significant (p < 0.05), and bioinformatics analyses of all 57 proteins revealed biology within hemostasis, coagulation cascades, the immune system, and the extracellular matrix. A protein–protein-interaction network revealed Fibronectin 1 as a central hub. Finally, technical validation confirmed MCAM, LBP, C1RL, and APOC3. We put forward novel biomarkers for incident AMI, a part of the proteome field where markers are surprisingly rare and where additional studies are highly needed.

23 September 2024 in Basic & Clinical Pharmacology & Toxicology
Verified
Journal Article
Open access
PFPalle Bach Nielsen Fruekilde
Palle Bach Nielsen Fruekilde
FNFlemming Nielsen
Flemming Nielsen
Long‐term sample stability of five atypical antipsychoticdrugs risperidone, paliperidone, clozapine, quetiapine and olanzapine and the antidepressant drug mirtazapine in serum was studied by use of a newly developed and validated analytical method based on solid‐phase extraction and liquid chromatography–tandem mass spectrometry. Ascorbic acid was used as an antioxidative agent to stabilize olanzapine during storage and sample preparation.We assessed analyte stability on long‐term storage in serum samples at 25°C, 5°C, −20°C and −80°C, and during five freeze–thaw cycles. Analytes were stable for 23 days at room temperature except for olanzapine and mirtazapine (17 days). All analytes were stable for at least 30 days at 5°C. All analytes were stable for 270 days at −20°C, except for paliperidone and mirtazapine with 60 days and 180 days, respectively. All analytes were stable for 270 days at −80°C. Furthermore, all analytes were stable for five freeze–thaw cycles.We recommend storage at −80°C when samples drawn for analysis of antipsychotic drugs are stored for more than 60 days, whereas a temperature of −20°C is sufficient for storage less than 60 days.

27 February 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
KJKristine Jung
Kristine Jung
MEMark Bremholm Ellebæk
Mark Bremholm Ellebæk
PDPer Damkier
Per Damkier
PFPalle Bach Nielsen Fruekilde
Palle Bach Nielsen Fruekilde
Sören MöllerSören Möller
Sören Möller
NQNiels Qvist
Niels Qvist
Background/Objectives: To prevent surgical site infections, the concentration of the administered antibiotic at the target compartment is important. We measured the concentrations of cefuroxime and metronidazole in the peritoneal fluid with microdialysis technique in patients undergoing surgery for secondary peritonitis (7 patients) and for inflammatory bowel disease (11 patients). Methods: All received 1.5 g of cefuroxime and 0.5 g of metronidazole every 8 hour during the postoperative period for a least 72 hours. Microdialysates covering 8 hours intervals were collected and the concentration of cefuroxime and metronidazole was measured using liquid chromatography mass spectrometry. Results: For metronidazole a concentration of ≥4 μg/mL was reached in all but one sample corresponding to the minimal inhibitory concentration (MIC) for most anaerobic bacteria strains. For cefuroxime a value of ≥4 μg/mL was reached in 88% of the samples in the peritonitis group and 93% of the samples in the IBD group corresponding to the MIC values for most gram-negative bacteria. A value of 16 ≥μg/ml corresponding to the MIC value for more resistant bacteria was reached in only 40% and 23% of the samples, respectively. Conclusions: Our results demonstrated that peritoneal microdialysis is a feasible method to study the diffusion of antibiotics into the peritoneal cavity. The method with measuring the accumulative concentration of the antibiotics in the peritoneal fluid corresponding to interval of drug administration may have the potential to add important information to the traditional pharmacodynamic parameters and relevant to reach optimal therapeutic effect.